Serial Number
97041301
Owner
Aptah Bio Inc.Attorney
Alyssa M. WorshamFirst Use Date
Feb 2, 2022
Filing Date
Sep 23, 2021
APTAH Trademark
Serial Number: 97041301
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
Legal Representation
Correspondence Address
Alyssa M. Worsham WILSON SONSINI GOODRICH & ROSATI
650 PAGE MILL ROAD
PALO ALTO, CA 94304-1050
United States
Trademark Details
Filing Date
September 23, 2021
Registration Date
Not Registered
First Use Anywhere
February 2, 2022
First Use in Commerce
February 2, 2022
Published for Opposition
November 29, 2022
Goods & Services
Pharmaceutical preparations for the configuration, modulation and correction of RNA transcript splicing, capping and tailing for the treatment of genetic diseases; pharmaceutical preparations for the configuration, modulation and correction of RNA for the treatment of genetic diseases; pharmaceutical preparations for restoring and reprograming RNA-protein interactions for the treatment of genetic diseases; pharmaceutical preparations for the treatment of genetic diseases associated with gene dysregulation, inhibition or suppression of gene expression; pharmaceutical preparations for the treatment of genetic diseases; gene therapy products, namely, molecules in the nature of genetically engineered tissues for controlling gene expression; medical molecular diagnostic tests for testing bodily fluid for the detection of genetic diseases; medical diagnostic tests for the detection of neurodegenerative, oncological and infectious diseases
Research and development of pharmaceuticals, namely, therapies for the configuration, modulation and correction of RNA transcript splicing, capping and tailing; scientific research and development of therapies in the fields of biotechnology, genetic medicine, gene therapy, DNA, RNA, molecules and proteins; pharmaceutical products design and development in the field of biomolecules for medical and scientific use, and medical treatment; pharmaceutical drug design and development featuring biomolecules
Biomolecules in the nature of gene therapy products, namely, genetically engineered stem cells in the nature of synthetic cDNAs for controlling gene expression for medical and scientific research
